The Cooper Companies, Inc. (COO) Stock

The Cooper Companies, Inc., along with its subsidiaries, specializes in the development, manufacturing, and global distribution of contact lenses and medical devices. Operating through two distinct segments, CooperVision and CooperSurgical, the company serves diverse healthcare needs across the Americas, Europe, Middle East, Africa, and Asia Pacific regions. The CooperVision segment focuses on providing a wide range of contact lenses, including spherical, toric, and multifocal lenses designed to address various vision impairments such as nearsightedness, farsightedness, astigmatism, presbyopia, and eye dryness. This segment caters to both individual consumers and professional healthcare providers seeking reliable and innovative eye care solutions.

In contrast, the CooperSurgical segment is dedicated to enhancing family and women's healthcare. It offers a comprehensive portfolio of medical devices and services, including fertility solutions, genomic testing, diagnostic tools, contraception, and surgical instruments. This segment's products support healthcare professionals globally in addressing critical reproductive health issues and improving patient outcomes. CooperSurgical's offerings range from surgical devices like PARAGARD and uterine manipulators to fertility consumables, embryo options, and advanced genetic testing technologies.

Founded in 1958 and headquartered in San Ramon, California, The Cooper Companies has established itself as a leader in the healthcare industry through its commitment to innovation, quality, and patient care. With a strong global presence and a focus on advancing both vision and women's health, The Cooper Companies continues to drive advancements in medical technology while expanding its reach to serve diverse healthcare markets worldwide.